News & Updates
Filter by Specialty:
Short nighttime sleepers at risk of long COVID, mental and CV diseases
Short nighttime sleepers are at higher risks of long COVID, depression and cardiovascular (CV) diseases than normal sleepers, according to three recent studies by researchers from the Chinese University of Hong Kong (CUHK).
Short nighttime sleepers at risk of long COVID, mental and CV diseases
03 Apr 2023
Long-term methylphenidate use does not stunt growth in children with ADHD
Long-term treatment with methylphenidate does not increase risks of growth impairment and psychiatric or neurological adverse events (AEs) in children and adolescents with attention deficit hyperactivity disorder (ADHD), according to the international ADDUCE study co-led by the University of Hong Kong (HKU) and the University of Melbourne.
Long-term methylphenidate use does not stunt growth in children with ADHD
03 Apr 2023
Tumour immune barrier determines immunotherapy efficacy in HCC
A tumour immune barrier (TIB) structure formed by the interaction of SPP1+ macrophages and cancer-associated fibroblasts (CAFs) appears to influence the efficacy of immunotherapy in patients with hepatocellular carcinoma (HCC), reveals a study.
Tumour immune barrier determines immunotherapy efficacy in HCC
01 Apr 2023
Secukinumab yields sustained positive effects on molecular, histopathologic psoriasis markers
Treatment with secukinumab leads to sustained clinical response among patients with psoriasis, with clinical response being associated with rapid and persistent normalization of keratin 16 (K16) and inflammatory gene expression for most patients, according to data from the ObePso-S study.
